New studies have suggested that the expression of Gli1 is related to prognosis in HER2 positive breast cancer, and Gli1 is regulated by HER2 via PI3K-Akt pathway in esophageal adenocarcinoma20,21. Here, ERBB2 is linked to breast carcinoma.